المؤلفون: Patino-Alonso C; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain; Department of Statistics, University of Salamanca, Salamanca, Spain. Electronic address: carpatino@usal.es., Gómez-Sánchez M; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain., Hernández-Rivas JM; Department of Medicine, University of Salamanca, Salamanca, Spain; Department of Hematology, Hospital Clínico Universitario, Salamanca, Spain; Center of Cancer Research, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., González-Porras JR; Department of Hematology, Hospital Clínico Universitario, Salamanca, Spain; Center of Cancer Research, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Bastida-Bermejo JM; Department of Hematology, Hospital Clínico Universitario, Salamanca, Spain; Center of Cancer Research, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Martín AA; Department of Hematology, Hospital Clínico Universitario, Salamanca, Spain; Center of Cancer Research, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Rodríguez-Sánchez E; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain; Department of Medicine, University of Salamanca, Salamanca, Spain., Recio-Rodríguez JI; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain; Department of Nurse and Physiotherapy, University of Salamanca, Salamanca, Spain., González-Sánchez J; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain; Department of Nurse and Physiotherapy, University of Salamanca, Salamanca, Spain., Maderuelo-Fernández JA; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain., García-Ortiz L; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain; Department of Biomedical and Diagnostic Sciences, University of Salamanca, Salamanca, Spain., Gómez-Marcos MA; Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute of Salamanca (IBSAL), 37005 Salamanca, Spain; Department of Medicine, University of Salamanca, Salamanca, Spain.

المصدر: Medicina clinica [Med Clin (Barc)] 2022 Jun 10; Vol. 158 (11), pp. 503-508. Date of Electronic Publication: 2021 Aug 13.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2* , Myeloproliferative Disorders*/complications , Myeloproliferative Disorders*/diagnosis , Vascular Stiffness*, Aged ; Female ; Humans ; Middle Aged ; Propensity Score

المؤلفون: Fernández-Caballero M; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Electronic address: marifc87@gmail.com., Jiménez Lorenzo MJ; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Morgades de la Fe M; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Ferrà Coll C; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Vives Polo S; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Abril Sabater L; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Navarro Ferrando JT; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Ribera Santasusana JM; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.

المصدر: Medicina clinica [Med Clin (Barc)] 2022 May 27; Vol. 158 (10), pp. 451-457. Date of Electronic Publication: 2021 Aug 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/therapy , Myelodysplastic Syndromes*/therapy , Myeloproliferative Disorders*, Humans ; Recurrence ; Retrospective Studies ; Risk Factors ; Transplantation Conditioning ; Transplantation, Homologous

عنوان ترانسليتريتد: Neoplasia de células dendríticas blásticas plasmacitoides. Estudio de tres casos.

المؤلفون: Sitges M; Servicio de Hematología Clínica, ICO-Badalona, Hospital Germans Trias i Pujol, Badalona, España; Instituto de Investigación contra la Leucemia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, España. Electronic address: martasitges90@gmail.com., Vives S; Servicio de Hematología Clínica, ICO-Badalona, Hospital Germans Trias i Pujol, Badalona, España; Instituto de Investigación contra la Leucemia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, España., Ribera JM; Servicio de Hematología Clínica, ICO-Badalona, Hospital Germans Trias i Pujol, Badalona, España; Instituto de Investigación contra la Leucemia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, España.

المصدر: Medicina clinica [Med Clin (Barc)] 2020 Jun 26; Vol. 154 (12), pp. 524-525. Date of Electronic Publication: 2019 Jul 23.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/diagnosis , Myeloproliferative Disorders* , Skin Neoplasms*/diagnosis, Dendritic Cells ; Humans

عنوان ترانسليتريتد: Neoplasias mieloproliferativas crónicas con cromosoma Filadelfia negativo y neoplasias linfoides concurrentes.

المؤلفون: Torregrosa JM; Unidad de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Instituto Murciano de Investigación Biosanitaria, Murcia, España., Soler G; Unidad de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Instituto Murciano de Investigación Biosanitaria, Murcia, España., Cancio S; Unidad de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Instituto Murciano de Investigación Biosanitaria, Murcia, España., Ferrer-Marin F; Unidad de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Instituto Murciano de Investigación Biosanitaria, Murcia, España. Electronic address: fferrermarin@gmail.com.

المصدر: Medicina clinica [Med Clin (Barc)] 2015 Oct 05; Vol. 145 (7), pp. 318-9. Date of Electronic Publication: 2015 Jan 22.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell/*complications , Lymphoma, Non-Hodgkin/*complications , Myeloproliferative Disorders/*complications, Adult ; Aged ; Biomarkers, Tumor/genetics ; Genetic Markers ; Humans ; Janus Kinase 2/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Lymphoma, Non-Hodgkin/genetics ; Male ; Middle Aged ; Mutation ; Myeloproliferative Disorders/genetics ; Philadelphia Chromosome ; Proto-Oncogene Proteins c-kit/genetics

عنوان ترانسليتريتد: Tratamiento actual de las neoplasias mieloproliferativas: frente a tres escenarios.

المؤلفون: Xicoy B; Hematología Clínica, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, España. Electronic address: bxicoy@iconcologia.net., Zamora L; Laboratorio Hematología, Biología Molecular,, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, España.

المصدر: Medicina clinica [Med Clin (Barc)] 2020 Feb 28; Vol. 154 (4), pp. 131-133. Date of Electronic Publication: 2019 Jul 24.

نوع المنشور: Editorial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Myeloproliferative Disorders/*therapy , Protein Kinase Inhibitors/*therapeutic use, Antineoplastic Agents/adverse effects ; Drug Resistance, Neoplasm ; Humans ; Imatinib Mesylate/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Niacinamide/analogs & derivatives ; Niacinamide/therapeutic use ; Nitriles ; Polycythemia Vera/drug therapy ; Primary Myelofibrosis/drug therapy ; Primary Myelofibrosis/genetics ; Protein Kinase Inhibitors/adverse effects ; Pyrazoles/therapeutic use ; Pyrimidines ; Recurrence ; Remission Induction ; Thrombocythemia, Essential/drug therapy ; Time Factors ; Withholding Treatment

عنوان ترانسليتريتد: Impacto clínico de la cuantificación de la carga mutacional de JAK2V617F en pacientes con neoplasias mieloproliferativas crónicas Ph negativas clásicas.

المؤلفون: Kerguelén Fuentes AE; Servicio de Hematología, Hospital Universitario La Paz, Madrid, Spain. anak534@gmail.com, Hernández-Maraver D, Lombardia L, Canales Albendea MA, Rodriguez de la Rúa A

المصدر: Medicina clinica [Med Clin (Barc)] 2012 Oct 13; Vol. 139 (9), pp. 373-8. Date of Electronic Publication: 2012 Jun 27.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Heterozygote* , Homozygote* , Phenotype* , Point Mutation*, Janus Kinase 2/*genetics , Myeloproliferative Disorders/*genetics, Adult ; Aged ; Aged, 80 and over ; Female ; Genetic Markers ; Humans ; Linear Models ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Myeloproliferative Disorders/complications ; Myeloproliferative Disorders/diagnosis ; Polycythemia Vera/complications ; Polycythemia Vera/diagnosis ; Polycythemia Vera/genetics ; Primary Myelofibrosis/complications ; Primary Myelofibrosis/diagnosis ; Primary Myelofibrosis/genetics ; Prognosis ; Real-Time Polymerase Chain Reaction ; Retrospective Studies ; Thrombocythemia, Essential/complications ; Thrombocythemia, Essential/diagnosis ; Thrombocythemia, Essential/genetics

عنوان ترانسليتريتد: Trombosis portal como primera manifestación de un síndrome mieloproliferativo crónico oculto.

المؤلفون: Santaeugenia S, Martí S, Maria Ribera J, Millá F

المصدر: Medicina clinica [Med Clin (Barc)] 2006 Oct 21; Vol. 127 (15), pp. 598-9.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print Cited Medium: Print ISSN: 0025-7753 (Print) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Portal Vein*, Myeloproliferative Disorders/*complications , Venous Thrombosis/*etiology, Adult ; Angiography ; Anticoagulants/therapeutic use ; Humans ; Male ; Myeloproliferative Disorders/diagnosis ; Myeloproliferative Disorders/drug therapy ; Treatment Outcome ; Venous Thrombosis/diagnosis ; Venous Thrombosis/drug therapy

عنوان ترانسليتريتد: Hemorragia suprarrenal bilateral y síndromes mieloproliferativos crónicos.

المؤلفون: Arellano-Rodrigo E

المصدر: Medicina clinica [Med Clin (Barc)] 2008 Jul 12; Vol. 131 (6), pp. 238.

نوع المنشور: Comment; Letter

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print Cited Medium: Print ISSN: 0025-7753 (Print) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Hemorrhage/*etiology , Myeloproliferative Disorders/*complications, Humans ; Myeloproliferative Disorders/genetics ; Syndrome

عنوان ترانسليتريتد: Valoración de la mutación V617F del gen JAK2 en síndromes mieloproliferativos crónicos con cromosoma Filadelfia negativo.

المؤلفون: Remacha AF; Departamento de Hematología, Hospital de Sant Pau, Barcelona, España. Aremacha@hsp.santpau.es, Puget G, Nomdedéu JF, Estivill C, Sardà MP, Canals C

المصدر: Medicina clinica [Med Clin (Barc)] 2006 Oct 28; Vol. 127 (16), pp. 601-4.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print Cited Medium: Print ISSN: 0025-7753 (Print) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Janus Kinase 2/*genetics , Myeloproliferative Disorders/*genetics, DNA/analysis ; Erythroid Precursor Cells ; Humans ; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative/genetics ; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative/pathology ; Mutation ; Myeloproliferative Disorders/pathology ; Philadelphia Chromosome ; Polycythemia Vera/genetics ; Polycythemia Vera/pathology ; Primary Myelofibrosis/genetics ; Primary Myelofibrosis/pathology ; Thrombocytosis/genetics ; Thrombocytosis/pathology

عنوان ترانسليتريتد: Síndrome de Budd-Chiari asociado a síndromes mieloproliferativos crónicos: análisis de seis casos.

المؤلفون: Cobo F; Escuela de Hematología Farreras-Valentí, Departamento de Medicina, Hospital Clínic i Provincial, Universidad de Barcelona., Cervantes F, García-Pagán JC, Bosch J, Rozman C, Montserrat E

المصدر: Medicina clinica [Med Clin (Barc)] 1996 Nov 16; Vol. 107 (17), pp. 660-3.

نوع المنشور: English Abstract; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print Cited Medium: Print ISSN: 0025-7753 (Print) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Budd-Chiari Syndrome/*etiology , Myeloproliferative Disorders/*complications, Adolescent ; Adult ; Budd-Chiari Syndrome/diagnosis ; Budd-Chiari Syndrome/therapy ; Female ; Humans ; Male ; Middle Aged ; Myeloproliferative Disorders/diagnosis ; Myeloproliferative Disorders/therapy